Researchers identify mitochondrial transfer between cancer and immune cells as a crucial mechanism for immune evasion. The ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...